1. Home
  2. FBIO vs PFX Comparison

FBIO vs PFX Comparison

Compare FBIO & PFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBIO
  • PFX
  • Stock Information
  • Founded
  • FBIO 2006
  • PFX 2010
  • Country
  • FBIO United States
  • PFX United States
  • Employees
  • FBIO N/A
  • PFX N/A
  • Industry
  • FBIO Biotechnology: Pharmaceutical Preparations
  • PFX Finance: Consumer Services
  • Sector
  • FBIO Health Care
  • PFX Finance
  • Exchange
  • FBIO Nasdaq
  • PFX Nasdaq
  • Market Cap
  • FBIO 88.7M
  • PFX 96.4M
  • IPO Year
  • FBIO N/A
  • PFX N/A
  • Fundamental
  • Price
  • FBIO $3.00
  • PFX $47.40
  • Analyst Decision
  • FBIO Strong Buy
  • PFX
  • Analyst Count
  • FBIO 2
  • PFX 0
  • Target Price
  • FBIO $16.50
  • PFX N/A
  • AVG Volume (30 Days)
  • FBIO 1.6M
  • PFX 846.0
  • Earning Date
  • FBIO 11-13-2025
  • PFX 08-06-2025
  • Dividend Yield
  • FBIO N/A
  • PFX 3.03%
  • EPS Growth
  • FBIO N/A
  • PFX N/A
  • EPS
  • FBIO N/A
  • PFX 3.06
  • Revenue
  • FBIO $59,301,000.00
  • PFX $23,958,590.00
  • Revenue This Year
  • FBIO $49.84
  • PFX $10.24
  • Revenue Next Year
  • FBIO $42.47
  • PFX N/A
  • P/E Ratio
  • FBIO N/A
  • PFX $15.45
  • Revenue Growth
  • FBIO N/A
  • PFX 7.47
  • 52 Week Low
  • FBIO $1.33
  • PFX $44.56
  • 52 Week High
  • FBIO $4.20
  • PFX $57.40
  • Technical
  • Relative Strength Index (RSI)
  • FBIO 45.50
  • PFX 45.16
  • Support Level
  • FBIO $2.72
  • PFX $47.20
  • Resistance Level
  • FBIO $3.24
  • PFX $48.45
  • Average True Range (ATR)
  • FBIO 0.29
  • PFX 0.25
  • MACD
  • FBIO -0.13
  • PFX -0.00
  • Stochastic Oscillator
  • FBIO 22.61
  • PFX 51.55

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

About PFX PhenixFIN Corporation

PhenixFIN Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.

Share on Social Networks: